medigraphic.com
ISSN 1665-2576 (Impreso)

2008, Número 4

<< Anterior Siguiente >>

Rev Mex Cir Endoscop 2008; 9 (4)


Impacto de la cirugía bariátrica sobre el síndrome metabólico

Rosales CM

Idioma: Español
Referencias bibliográficas: 63
Paginas: 177-182
Archivo PDF: 114.41 Kb.


RESUMEN

La obesidad es un problema de salud mundial que representa un riesgo para el desarrollo de alteraciones metabólicas como son: diabetes tipo 2 (DM 2), hipertensión, dislipidemia, esteatosis hepática no alcohólica, síndrome de ovarios poliquísticos e hiperuricemia, además de otras enfermedades que incluyen: apnea obstructiva del sueño, enfermedad cardiovascular y cáncer. Es uno de los componentes principales del síndrome metabólico (SM), el cual incrementa el riesgo para presentar diabetes, cardiopatía isquémica y eventos vasculares cerebrales. La obesidad incrementa la mortalidad y costos de salud. El tratamiento de la obesidad a base de modificaciones en la dieta y estilo de vida son fundamentales, sin embargo los resultados a largo plazo no son favorables debido a la falta de apego y abandono. La cirugía bariátrica ha surgido como herramienta efectiva en el tratamiento a largo plazo de la obesidad severa, logrando una mejoría en los componentes metabólicos asociados, riesgo cardiovascular y mortalidad. La prevalencia de síndrome metabólico después de la cirugía bariátrica disminuye considerablemente. En este artículo se revisan los efectos de la cirugía bariátrica sobre el síndrome metabólico y sus componentes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health. Obes Res 1998; 6(Suppl 2): 51S-209S.

  2. Obesity and overweight (Fact Sheet No. 311). Geneva, Switzerland: World Health Organization; 2006.

  3. Bessesen DH. Update on Obesity. J Clin Endocrinol Metab 2008; 93(6): 2027-2034

  4. Instituto Nacional de Salud Pública, Secretaría de Salud. Encuesta Nacional de Salud y Nutrición 2006.

  5. Popkin B. An overview on the nutrition transition and its health implications: The Bellagio meeting. Public Health Nutr 2002; 5(1A): 93-103.

  6. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529.

  7. Overweight, obesity, and health risk: National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000; 160: 898-904.

  8. World Health Organization. World Health Report 2002.

  9. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993; 44: 121-31.

  10. Garber A. The metabolic syndrome. Med Clin N Am 2004; 88: 837-846.

  11. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289: 187-193.

  12. Powers KA, Rehrig ST, Jones DB. Financial impact of obesity and bariatric surgery. Med Clin North Am 2007; 91(3): 321-338.

  13. Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity what fits whom? Diabetes Care 2008; 31 (Suppl. 2): S269-S277.

  14. North American Association for the Study of Obesity and the National Heart, Lung, and Blood Institute. The Practical Guide: Identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, Md: National Institutes of Health; 2000. NIH publication 00-4084.

  15. Zimmet P, Shaw J, Alberti KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 2003; 20: 693-702.

  16. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and metaanalysis. JAMA 2004; 292: 1724-37.

  17. Kini S, Herron D, Yanagisawa RT. Bariatric surgery for morbid obesity a cure for metabolic syndrome? Med Clin N Am 2007; 91: 1255-1271.

  18. Folli F, Pontiroli AE, Schwesinger WH. Metabolic aspects of bariatric surgery. Med Clin N Am 2007; 91: 393-414.

  19. Ashrafian H, le Roux CW, Darzi A, Athanasiou T. Effects of bariatric surgery on cardiovascular function. Circulation 2008; 118: 2091-2102.

  20. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89(6): 2548-2556.

  21. Theuma P, Fonseca VA. Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis. Curr Diab Rep 2003; 3: 248-54.

  22. Phillippa J, DeFronzo RA et al. Metabolic syndrome: Definition, pathophysiology, and mechanisms. Am Heart J 2005; 149: 33-45.

  23. Ahmed I, Goldstein BJ. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Mt Sinai J Med 2006; 73(5): 759-68.

  24. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III). JAMA 2001; 285: 2486-97.

  25. Grundy SM, Brewer HB et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433.

  26. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2005.

  27. Instituto Nacional de Salud Pública, Secretaría de Salud. Encuesta Nacional de Salud 2000. Instituto Nacional de Salud Pública.

  28. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: a statement for health professionals. An American Heart Association/National Heart Lung and Blood Institute Scientific statement. Circulation 2005; 112: 2735-52.

  29. Roglic G, Unwin N, Bennet PH et al. The burden of mortality attributable to diabetes. Diabetes Care 2005; 28: 2130-5.

  30. O’Brien PE, Dixon McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006; 16(8): 1032-1040.

  31. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li ZP, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta analysis: surgical treatment of obesity. Annals of Internal Medicine 2005; 142: 547-559.

  32. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H. Swedish obese subjects study scientific group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med 2004; 351(26): 2683-93.

  33. National Institutes of Health Consensus Development Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med 1991; 115: 956-961.

  34. AACE/TOS/ASMBS Bariatric Surgery Guidelines. Endocr Pract 2008; 14(Suppl 1): 1-83.

  35. Buchwald H. Consensus Conference Panel, bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. J Am Coll Surg 2005; 200: 593-604.

  36. O’Brien PE, Dixon JB, Laurie C et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program. Ann Intern Med 2006; 144: 625-633.

  37. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.

  38. Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484.

  39. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751-756.

  40. Torquati A, Lutfi R, Abumrad N et al. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 2005; 9: 1112-8.

  41. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 2003; 52: 101.

  42. Kopp HP, Kopp CW, Festa A et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 2003; 23: 1042-1047.

  43. Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-2615.

  44. le Roux CW, Aylwin SJ, Batterham RL et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108-14.

  45. Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery. Clin Endocrinol 2008; 69: 173-179.

  46. Morinigo R, Moize V, Musri M, Lacy AM, Navarro S, Marín JL, Delgado S, Casamitjana R, Vidal J. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006; 91: 1735-40.

  47. Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339-52.

  48. Zlabek JA, Grimm MS, Larson CJ, Mathiason MA, Lambert PJ, Kothari SN. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis 2005; 1: 537-542.

  49. Dixon JB, O’Brien PE. Lipid profile in the severely obese: changes with weight loss after Lap-Band surgery. Obes Res 2002; 10: 903-910.

  50. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751-756.

  51. Fernstrom JD, Courcoulas AP, Houck PR, Fernstrom MH. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery. Arch Surg 2006; 141: 276-283.

  52. Sjöström CD, Peltonen M, Sjöström L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res 2001; 9: 188-195.

  53. Eid GM, Cottam DR, Velcu LM et al. Effective treatment of polycystic ovarian syndrome with Roux-en Y gastric bypass. Surg Obes Relat Dis 2005; 1: 77-80.

  54. Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F et al. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005; 90: 6364-9.

  55. Mattar SG, Velcu LM, Rabinovitz M, Demetris AJ, Krasinskas AM, Barinas-Mitchell E, Eid GM, Ramanathan R, Taylor DS, Schauer PR. Surgically induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome [with discussion]. Ann Surg 2005; 242: 610-620.

  56. Dixon JB. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 141-154.

  57. Madan AK, Orth W, Ternovits CA et al. Metabolic syndrome: yet another co-morbidity gastric bypass helps cure. Surg Obes Relat Dis 2006; 2: 48-51.

  58. Morinigo R, Casamitjana R, Delgado S et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care 2007; 30(7): 1906-1908.

  59. Batsis JA, Romero-Corral A, Collazo-Clavell ML, Sarr MG, Somers VK, Lopez-Jimenez F. Effect of bariatric surgery on the metabolic syndrome: A population-based, long-term controlled study. Mayo Clin Proc 2008; 83(8): 897-906.

  60. Pontiroli AE, Pizzocri P, Librenti MC et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002; 87: 3555-61.

  61. Christou NV, Sampalis JS, Liberman M et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-24.

  62. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM. Swedish obese subjects study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007: 357(8): 741-52.

  63. Pratt GM, McLees B, Pories WJ. The ASBS bariatric surgery centers of excellence program: a blueprint for quality improvement. Surg Obes Relat Dis 2006; 2: 497-503.




2020     |     www.medigraphic.com